Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Argellati

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Anticancer Research|December 11, 2012
Effects of bicalutamide and 4OH-tamoxifen on androgen-regulated gene expression in the LNCaP cell lineRosa Mangerini, Francesca Argellati, Ulrich Pfeffer, et al.
Molecular Aspects of Medicine|February 20, 2007
Vitamin E and neurodegenerative diseasesRoberta Ricciarelli, Francesca Argellati, Maria A Pronzato, et al.
Anticancer Research|March 14, 2013
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell linesFrancesca Argellati, Pier Vitale Nuzzo, Francesco Ricci, et al.
Brain Research|September 7, 2007
In vitro effect of PPAR-gamma2 Pro12Ala polymorphism on the deposition of Alzheimer's amyloid-beta peptidesCristina d'Abramo, Jean-Marc Zingg, Antonio Pizzuti, et al.
Clinical Genitourinary Cancer|March 25, 2014
Periostin: a novel prognostic and therapeutic target for genitourinary cancer?Pier Vitale Nuzzo, Giulia Buzzatti, Francesco Ricci, et al.
IUBMB Life|April 13, 2006
Evidence against the overexpression of APP in Down syndromeFrancesca Argellati, Sara Massone, Cristina d'Abramo, et al.
International Journal of Cancer|May 22, 2015
Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgeryFrancesco Boccardo, Alessandra Rubagotti, Pier Vitale Nuzzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2008
Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-BFrancesca Argellati, Cinzia Domenicotti, Mario Passalacqua, et al.
International Journal of Molecular Sciences|July 31, 2015
Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)Pier Vitale Nuzzo, Alessandra Rubagotti, Francesca Argellati, et al.
Biochemical and Biophysical Research Communications|August 31, 2007
Downregulation of myosin II-B by siRNA alters the subcellular localization of the amyloid precursor protein and increases amyloid-beta deposition in N2a cellsSara Massone, Francesca Argellati, Mario Passalacqua, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anticancer Research|December 11, 2012
Effects of bicalutamide and 4OH-tamoxifen on androgen-regulated gene expression in the LNCaP cell lineRosa Mangerini, Francesca Argellati, Ulrich Pfeffer, et al.
Molecular Aspects of Medicine|February 20, 2007
Vitamin E and neurodegenerative diseasesRoberta Ricciarelli, Francesca Argellati, Maria A Pronzato, et al.
Anticancer Research|March 14, 2013
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell linesFrancesca Argellati, Pier Vitale Nuzzo, Francesco Ricci, et al.
Brain Research|September 7, 2007
In vitro effect of PPAR-gamma2 Pro12Ala polymorphism on the deposition of Alzheimer's amyloid-beta peptidesCristina d'Abramo, Jean-Marc Zingg, Antonio Pizzuti, et al.
Clinical Genitourinary Cancer|March 25, 2014
Periostin: a novel prognostic and therapeutic target for genitourinary cancer?Pier Vitale Nuzzo, Giulia Buzzatti, Francesco Ricci, et al.
IUBMB Life|April 13, 2006
Evidence against the overexpression of APP in Down syndromeFrancesca Argellati, Sara Massone, Cristina d'Abramo, et al.
International Journal of Cancer|May 22, 2015
Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgeryFrancesco Boccardo, Alessandra Rubagotti, Pier Vitale Nuzzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 24, 2008
Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-BFrancesca Argellati, Cinzia Domenicotti, Mario Passalacqua, et al.
International Journal of Molecular Sciences|July 31, 2015
Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)Pier Vitale Nuzzo, Alessandra Rubagotti, Francesca Argellati, et al.
Biochemical and Biophysical Research Communications|August 31, 2007
Downregulation of myosin II-B by siRNA alters the subcellular localization of the amyloid precursor protein and increases amyloid-beta deposition in N2a cellsSara Massone, Francesca Argellati, Mario Passalacqua, et al.
Pageof 1